• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Flooded by the torrent: the COVID-19 drug pipeline.

作者信息

Mullard Asher

出版信息

Lancet. 2020 Apr 18;395(10232):1245-1246. doi: 10.1016/S0140-6736(20)30894-1.

DOI:10.1016/S0140-6736(20)30894-1
PMID:32305088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7162641/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a33/7162641/2abfac063a89/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a33/7162641/bb67ce1892f6/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a33/7162641/2abfac063a89/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a33/7162641/bb67ce1892f6/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a33/7162641/2abfac063a89/fx2_lrg.jpg

相似文献

1
Flooded by the torrent: the COVID-19 drug pipeline.被洪流淹没：新冠病毒药物研发进程
Lancet. 2020 Apr 18;395(10232):1245-1246. doi: 10.1016/S0140-6736(20)30894-1.
2
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.洛匹那韦/利托那韦未能缩短台湾轻症肺炎患者 SARS-CoV-2 脱落持续时间。
J Microbiol Immunol Infect. 2020 Jun;53(3):488-492. doi: 10.1016/j.jmii.2020.03.032. Epub 2020 Apr 3.
3
Covid-19 - The Search for Effective Therapy.新冠病毒-19：寻找有效疗法
N Engl J Med. 2020 May 7;382(19):1851-1852. doi: 10.1056/NEJMe2005477. Epub 2020 Mar 18.
4
Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.洛匹那韦/利托那韦治疗严重急性呼吸综合征、中东呼吸综合征和 COVID-19：系统评价。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8592-8605. doi: 10.26355/eurrev_202008_22659.
5
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
6
Early triple antiviral therapy for COVID-19.新冠肺炎的早期三联抗病毒治疗
Lancet. 2020 Nov 7;396(10261):1487-1488. doi: 10.1016/S0140-6736(20)32274-1.
7
SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial.新型冠状病毒感染患者使用诺华芬治疗后清除病毒效果：一项随机、开放标签、平行分组试验。
Int J Infect Dis. 2020 Oct;99:84-91. doi: 10.1016/j.ijid.2020.07.053. Epub 2020 Aug 3.
8
Early triple antiviral therapy for COVID-19 - Authors' reply.COVID-19的早期三联抗病毒治疗——作者回复
Lancet. 2020 Nov 7;396(10261):1488. doi: 10.1016/S0140-6736(20)32268-6.
9
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.抗病毒联合治疗在新冠病毒感染有症状患者中的安全性和有效性 - 一项随机对照试验（SEV-COVID 试验）：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 20;21(1):866. doi: 10.1186/s13063-020-04774-5.
10
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.高剂量干扰素β-1a与低剂量干扰素β-1a（基础治疗方案）相比对中度至重度COVID-19的有益效果研究：一项随机对照试验研究方案的结构化总结
Trials. 2020 Oct 26;21(1):880. doi: 10.1186/s13063-020-04812-2.

引用本文的文献

1
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001.两名新冠肺炎呼吸衰竭患者在给予抗癌小分子药物RRx-001后的临床病程
Int Med Case Rep J. 2022 Dec 15;15:735-738. doi: 10.2147/IMCRJ.S389690. eCollection 2022.
2
COVID-19 Vaccine Hesitancy among Pregnant Women Attending Antenatal Clinics in Pakistan: A Multicentric, Prospective, Survey-Based Study.巴基斯坦产前诊所孕妇对 COVID-19 疫苗的犹豫：一项多中心、前瞻性、基于调查的研究。
Viruses. 2022 Oct 25;14(11):2344. doi: 10.3390/v14112344.
3
Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials.
应对 COVID-19 的新兴疗法：更多临床试验信息的价值。
Value Health. 2022 Aug;25(8):1268-1280. doi: 10.1016/j.jval.2022.03.016. Epub 2022 Apr 28.
4
A network biology approach to identify crucial host targets for COVID-19.一种网络生物学方法，用于鉴定 COVID-19 的关键宿主靶标。
Methods. 2022 Jul;203:108-115. doi: 10.1016/j.ymeth.2022.03.016. Epub 2022 Mar 29.
5
Minimum Manufacturing Costs, National Prices, and Estimated Global Availability of New Repurposed Therapies for Coronavirus Disease 2019.2019年冠状病毒病新型重新利用疗法的最低制造成本、国家价格及全球可及性估计
Open Forum Infect Dis. 2021 Dec 17;9(1):ofab581. doi: 10.1093/ofid/ofab581. eCollection 2022 Jan.
6
The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials.2022 年 IUPHAR/BPS 药理学指南：为 COVID-19、疟疾和抗菌药物药物治疗学。
Nucleic Acids Res. 2022 Jan 7;50(D1):D1282-D1294. doi: 10.1093/nar/gkab1010.
7
COVID-19 Vaccine in Pregnant and Lactating Women: A Review of Existing Evidence and Practice Guidelines.孕妇和哺乳期妇女的新冠疫苗：现有证据与实践指南综述
Infect Dis Rep. 2021 Jul 31;13(3):685-699. doi: 10.3390/idr13030064.
8
Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome.冷冻电镜和反义技术靶向 SARS-CoV-2 RNA 基因组的 28kDa 移码刺激元件。
Nat Struct Mol Biol. 2021 Sep;28(9):747-754. doi: 10.1038/s41594-021-00653-y. Epub 2021 Aug 23.
9
SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies-a narrative review.SARS-CoV-2 感染与妊娠及妊娠相关情况：关注问题、挑战、管理及缓解策略——叙述性综述。
J Infect Public Health. 2021 Jul;14(7):863-875. doi: 10.1016/j.jiph.2021.04.005. Epub 2021 Apr 23.
10
Role of different types of nanomaterials against diagnosis, prevention and therapy of COVID-19.不同类型纳米材料在新冠病毒肺炎诊断、预防及治疗中的作用
Sustain Cities Soc. 2021 Sep;72:103046. doi: 10.1016/j.scs.2021.103046. Epub 2021 May 25.